share

(9S)-9-Deoxo-9-[[(4-Fluorophenyl)Sulfonyl]Amino]Erythromycin CAS NO 61066-20-4


Unit Price:

CAS No.:61066-20-4

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

(9S)-9-Deoxo-9-[[(4-Fluorophenyl)Sulfonyl]Amino]Erythromycin is a chemically modified derivative of the macrolide antibiotic erythromycin, designed for enhanced stability and targeted biological activity. This compound is of significant interest in pharmaceutical research and development, particularly for creating novel antibacterial agents and exploring structure-activity relationships. It serves as a critical intermediate for researchers and manufacturers in the pharmaceutical and biotechnology sectors focused on advanced antibiotic synthesis and medicinal chemistry.

Application

  • Pharmaceutical Intermediate: A key building block in the synthesis of novel macrolide antibiotics and investigational drugs.
  • Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies to develop new antibacterial agents with improved efficacy.
  • Biochemical Research: Employed as a tool compound to study bacterial protein synthesis inhibition and resistance mechanisms.
  • API Development: Serves as a precursor in the development and scale-up of active pharmaceutical ingredients (APIs) for clinical trials.
  • Reference Standard: Utilized as a high-purity analytical standard for quality control and method development in laboratories.

Basic Information

Product Name (9S)-9-Deoxo-9-[[(4-Fluorophenyl)Sulfonyl]Amino]Erythromycin
CAS No. 61066-20-4
Molecular Formula C37H67FN2O12S
Molecular Weight 782.99 g/mol
Synonyms 9-Deoxo-9-[(4-fluorophenyl)sulfonyl]aminoerythromycin; 9(S)-9-Deoxo-9-[(p-fluorophenylsulfonyl)amino]erythromycin; Erythromycin 9-[(4-fluorophenyl)sulfonyl]imine derivative; 9-N-[(4-Fluorophenyl)sulfonyl]erythromycylamine; (9S)-9-Deoxo-9-[(4-fluorobenzenesulfonyl)amino]erythromycin; 9-Deoxo-9-(4-fluorophenylsulfonamido)erythromycin; A-69334; Antibiotic A-69334
EINECS Contact for details

Quality Control

Our (9S)-9-Deoxo-9-[[(4-Fluorophenyl)Sulfonyl]Amino]Erythromycin is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation (IR, NMR), to ensure it meets the high standards required for pharmaceutical research. Certificates of Analysis (COA) with detailed chromatographic data are provided to guarantee traceability, consistency, and compliance with your specifications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed in a dry environment to prevent degradation. For long-term storage, consider desiccants or inert atmosphere.

Specification

Item Specification
Appearance White to off-white powder
Identification (IR) Conforms to reference spectrum
Identification (HPLC) Retention time corresponds to reference standard
Assay (HPLC) ≥ 95.0%
Related Substances (HPLC) Total impurities ≤ 5.0% Any single unknown impurity ≤ 1.0%
Water Content (KF) ≤ 5.0%
Residue on Ignition ≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.